F. Ecklund

Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.

J. Ghali, T. DeMarco, A. Feldman, 2007, Journal of cardiac failure.

Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial

D. Kass, L. DiCarlo, S. Krueger, 2006, Circulation.

Review Article Influence of Diabetes on Cardiac Resynchronization Therapy With or Without Defibrillator in Patients With Advanced Heart Failure

J. Ghali, T. DeMarco, A. Feldman, 2007 .

Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure

Leslie Saxon, John Boehmer, Arthur M. Feldman, 2006, Circulation.

Influence of Left Ventricular Lead Location on Outcomes in the COMPANION Study

Thomas Guarnieri, Brian Olshansky, Anupama Rao, 2009, Journal of cardiovascular electrophysiology.

Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.

J. Ghali, M. Higginbotham, A. Feldman, 2008, Journal of cardiac failure.

Male gender and chronic obstructive pulmonary disease predict a poor clinical response in patients undergoing cardiac resynchronisation therapy

B. M. Dalen, J. Daubert, D. Atar, 2011, International journal of clinical practice.